- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| LIPIGON PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 04.05. | Lipigon Pharmaceuticals AB - Removal from trading on Nasdaq First North Growth Market | 173 | GlobeNewswire | According to section 2.3.7 of the Nasdaq First North Growth Market Rulebook, an issuer shall be able to demonstrate ongoing business operations.
According to section 8.2.7 of the Nasdaq First... ► Artikel lesen | |
| 20.04. | The observation status for Lipigon Pharmaceuticals AB is updated | 136 | GlobeNewswire | On February 20, 2026, the shares in Lipigon Pharmaceuticals AB (the "Company") were given observation status with reference to information that the Company had limited liquidity and was dependent... ► Artikel lesen | |
| 20.02. | Lipigon Pharmaceuticals AB receives observation status | 557 | GlobeNewswire | On February 16, 2026, Lipigon Pharmaceuticals AB (the "Company") disclosed a press release providing, inter alia, an update regarding the Company's drug candidate Lipisense. The press release also... ► Artikel lesen | |
| 14.10.25 | Lipigon Pharmaceuticals AB: Lipigon Pharmaceuticals reports last patient visit in the three-month follow-up of its Phase II clinical study with Lipisense | 216 | GlobeNewswire (Europe) | Lipigon Pharmaceuticals AB (publ) today announced that the last patient in the company's Phase II clinical study of Lipisense® has completed the three-month follow-up. The study includes a total of... ► Artikel lesen | |
| 06.07.25 | Lipigon Pharmaceuticals AB: Lipigon Pharmaceuticals Enrolls Last Patient in Phase II Study with Lipisense | 345 | GlobeNewswire (Europe) | This press release is an English translation of the Swedish press release published by Lipigon Pharmaceuticals AB on 2025-06-23.
Lipigon Pharmaceuticals AB announced today that the last patient has... ► Artikel lesen |
5 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| KHIRON LIFE SCIENCES | 0,029 | -100,00 % | Khiron Life Sciences Corp: Khiron Life Sciences warrants to expire Nov. 26 | ||
| CHRISTINA LAKE CANNABIS | 0,009 | -57,50 % | Christina Lake Cannabis Corp: Christina Lake investor Milia acquires 5.03M shares | ||
| PSYCHED WELLNESS | 0,004 | 0,00 % | Psyched Wellness Ltd.: Psyched Wellness Highlights U.S. Federal Policy Momentum Supporting Psychedelic Sector | Toronto, Ontario--(Newsfile Corp. - April 23, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution... ► Artikel lesen | |
| GREENRISE GLOBAL BRANDS | 0,004 | 0,00 % | XFRA C4T: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILGREENRISE GLOBAL... ► Artikel lesen | |
| NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.04.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 23.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.04.2026ISIN NameAU000000BMG3 BMG... ► Artikel lesen | |
| BETTERLIFE PHARMA | 0,035 | 0,00 % | BetterLife Pharma Inc.: BetterLife Pharma to Participate in YAFO Capital Access Asia Partnering Forum During JPM Week in San Francisco | Vancouver, British Columbia--(Newsfile Corp. - January 6, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biopharmaceutical company... ► Artikel lesen | |
| ADDEX THERAPEUTICS | 0,045 | 0,00 % | Addex Therapeutics: Addex Reports Full Year 2025 Financial Results and Provides Corporate Update | GABAB PAM chronic cough candidate continued towards clinic after demonstrating robust anti-tussive activity in multiple disease modelsContinued to reposition dipraglurant mGlu5 NAM for brain injury... ► Artikel lesen | |
| MEDIPHARM LABS | 0,049 | 0,00 % | MediPharm Labs Corp.: MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results | ||
| PROMINO NUTRITIONAL SCIENCES | 0,015 | 0,00 % | Promino Nutritional Sciences, Inc.: Promino Responds to Growing Demand for Muscle Health Support as Health Canada Expands Access to Semaglutide | Rejuvenate Muscle Health Adds Prominent GLP-1 Support Call-Out to New Packaging Set to Debut Later This Month Across North America; ECRM "Best Drink 2025" Validation; Promino NSF Certified for Sport... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,013 | 0,00 % | ARGENT BIOPHARMA LIMITED: Final Director's Interest Notice - GH | ||
| CANNABIST COMPANY | 0,020 | 0,00 % | Cannabist Co Holdings Inc. - 8-K, Current Report | ||
| IANTHUS CAPITAL | 0,001 | 0,00 % | iAnthus GAAP EPS of $0.00, revenue of $33.51M | ||
| CENTR BRANDS | 0,019 | -24,49 % | Centr Brands Corp (2): Centr Brands arranges $50,000 debenture financing | ||
| RESTART LIFE SCIENCES | 0,054 | -9,24 % | Restart Life Sciences Corp.: Restart Life Sciences Announces Dedicated Purchase Order Financing Through Private Placement Offering | Vancouver, British Columbia--(Newsfile Corp. - May 8, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce a purchase... ► Artikel lesen | |
| AYR WELLNESS | 0,050 | 0,00 % | Ayr Wellness Inc.: AYR Wellness Announces Closing of Exit Facility and Related Transactions | MIAMI, April 10, 2026 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announces the initial... ► Artikel lesen |
Das Unternehmen LIPIGON PHARMACEUTICALS AB kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIPIGON PHARMACEUTICALS AB finden Sie auf Wallstreet Online.